New drug tested to slow Muscle-Wasting disease
Disease control
Completed
This study tested an investigational drug called ABC008 for adults with inclusion body myositis, a rare muscle-wasting disease. It aimed to see if the drug could safely slow the decline in muscle strength and function compared to a placebo. The trial involved 272 participants and…
Phase: PHASE2, PHASE3 • Sponsor: Abcuro, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC